Can You Pass the (Deoxyribonucleic) Acid Test?
By Center for Environmental Health,
Center for Environmental Health [with CGS's Pete Shanks]
| 03. 17. 2014
For just $99, genetic test company 23andme offered to test your DNA for everything from heart disease risk to your chance of going bald. Kira Peikoff wondered what DNA testing from 23andme and two other companies would tell her—and the results were surprising. We’ll also talk to geneticist Dr. David Ng. His story in McSweeny’s, “Congratulations, Your Ineffectual Genetic Test Results Have Arrived” pokes fun at the “direct-to-consumer” genetic testing industry. Then Dr. Stuart Newman fills us in on epigenetics, evolutionary developmental biology, and why the Lamarck versus Darwin debate may be old news. Finally, advocate Pete Shanks on the “promise” of GMO humans and the threat of techno-eugenics.
Check out this episode.
Download here, or subscribe via iTunes.
Kira Peikoff is an author and Masters student in bioethics at Columbia University. Her New York Times article in December exposed the fallacies of direct-to-consumer genetic testing (see more resources on genetic test companies below). Check out her debut novel Living Proof (and look for her upcoming 2nd novel in the fall) on her website.
David Ng is...
Related Articles
By Emma McDonald Kennedy
| 10.29.2026
At the beginning of Nathan Fielder and Lance Oppenheim’s blockbuster documentary You Can See Everything, Billy Evans (partner of Theranos founder and convicted fraudster Elizabeth Holmes), says that they decided to do the film for one purpose: “radical transparency.” As they work on “Theranos 2.0,” Evans and Holmes want to show the public that she has been misunderstood –– painted as a liar and a fraud in the public imagination (and the courts) despite, as she claims in the...
By Jonquilyn Hill, Vox | 10.18.2026
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...